Back

ATTR-CM: understanding patient burden and risk acceleration

30 August 2026 (12:35 - 12:50)
Organised by: Logo
Congress Presentation Part of: ATTR-CM: redefining risk to optimise patient outcomes Cardiac Amyloidosis Open Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Thibaud Damy

University Hospital Henri Mondor, Creteil (France)

4 More presentations in this session

Presentation thumbnail
Introduction
Professor A. Yilmaz (Muenster, DE)
Video
Presentation thumbnail
Changing the trajectory: interventions to mitigate risk
Doctor E. Gonzalez Lopez (Madrid, ES) Doctor E. Joyce (Dublin, IE)
Video
Presentation thumbnail
Responding to residual risk: identifying and preventing disease progression
Doctor E. Gonzalez Lopez (Madrid, ES) Doctor F. Cappelli (Florence, IT)
Video
Presentation thumbnail
Closing remarks
Professor A. Yilmaz (Muenster, DE)
Slides Video

Access the full session

Session thumbnail
ATTR-CM: redefining risk to optimise patient outcomes
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 12:35 CET
You may be interested in
thumbnail
Congress Session
Time matters in transthyretin amyloid cardiomyopathy (ATTR-CM): emerging artificial intelligence approaches to screening and clinical considerations for treatment timing
28 August 2026
thumbnail
Congress Session
How to manage cardiac amyloidosis
13 May 2024
thumbnail
Congress Presentation
How do long-term data inform real-world decisions in ATTR-CM?
29 August 2026
thumbnail
Congress Session
Inside the image: solving the riddle of ATTR-CM with imaging
12 December 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources